Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall DEPUY ASR 300 ACETABULAR CUP SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
  Class 2 Device Recall DEPUY ASR 300 ACETABULAR CUP SYSTEM see related information
Date Initiated by Firm August 23, 2010
Date Posted March 24, 2011
Recall Status1 Terminated 3 on August 29, 2013
Recall Number Z-1797-2011
Recall Event ID 57177
510(K)Number K073413  
Product Classification Prothesis, hip, semi-constrained (metal uncemented acetabular component - Product Code KWA
Product ASR 300 Size 48, DEPUY ASR 300 ACETABULAR CUP SYSTEM.

The DePuy ASR 300 Acetabular Cup System is part of a modular system designed to replace the natural articular surface of the hip joint in total hip replacement. The acetabular cup is designed as cobalt-chrome molybdenum (CoCrMo) alloy one-piece cup. The outer surface of the cup has a porous coating with the addition of a hydroxyapatite (HA) coating. The cups feature three spikes for adjunct fixation and are available in ten sizes.

Prescription Use, Sterile

The DePuy ASR 300 Acetabular Cup System is part of a modular system designed to replace the natural articular surface of the hip joint in total hip replacement. The acetabular cup is designed as cobalt-chrome molybdenum (CoCrMo) alloy one-piece cup. The outer surface of the cup has a porous coating with the addition of a hydroxyapatite (HA) coating. The cups feature three spikes for adjunct fixation and are available in ten sizes. The device is indicated for use in total hip replacement procedures for patients suffering severe pain and disability due to structural damage in the hip joint from rheumatoid arthritis, osteoarthritis, post-traumatic arthritis, collagen disorders, avascular necrosis, and nonunion of femoral fractures. Use of the prosthesis is also indicated for patients with congenital hip dysplasia, slipped capital femoral epiphysis and disability due to previous fusion, where bone stock is inadequate for other reconstruction techniques. Porous-coated ASR 300 Acetabular Cups are indicated for cementless application. The device is part of a modular system for use in total hip replacement in which the acetabular component articulates with a femoral component. The DePuy ASR 300 Acetabular Cup System is compatible with ASR femoral components.
Code Information Part Number 999830748, Size 48, All lots.
Recalling Firm/
Manufacturer		 Depuy Orthopaedics, Inc.
700 Orthopaedic Dr
Warsaw IN 46582-3994
For Additional Information Contact ASR Helpline
888-627-2677
Manufacturer Reason
for Recall		 As part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials, internal complaints data and unpublished clinical research reports. DePuy Orthopaedics issued a Field Safety Notice in March 2010 after receiving new data from the
FDA Determined
Cause 2		 Device Design
Action DePuy Orthopaedics issued a Field Safety Notice in March 2010 to all affected customers. The Notice identified the product, the problem, and the action to be taken by the customer. Customers were instructed to share the Field Safety Notice with their organization and any organization where the ASR products may have been transferred. Customer were instructed not to implant the ASR devices. Patients who received the ASR System should be informed of this recall and instructed to return for a follow up visit. Patients with radiographic changes indicative of product failure should be addressed according to normal procedures. All other patients should be followed according to the April 22, 2010, and May 25, 2010 UK Medicines and Healthcare products Regulatory Agency (MHRA) Device Alerts. Follow up for all patients implanted with ASR acetabular cups at least annually for five years postoperatively. Beyond five years, follow up in accordance with locally agreed protocols. For patients who are symptomatic or implanted with a cup angle greater than 45 degrees, particulary where a small component has been implanted.: " Consider measuring cobalt and chromium ion levels in whle blood and/or performing cross sectional imaging including MRI or ultrasound scans. " If metal ion levels in whole blood are elevated above 7 parts per billion (ppb) for either metal ion, a second test should be performed three months after the first in order to identify patients who require closer surveillance, which may include cross sectional imaging " If MRI or ultrasound scan reveals soft tissue reactions, fluid collections or tissue masses, then revision surgery should be considered. DePuy representatives were to assist with returns of any remaining inventory. For questions regarding this recall call 574-372-7333.
Quantity in Commerce 353
Distribution Worldwide
Total Product Life Cycle TPLC Device Report
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
510(K) Database 510(K)s with Product Code = KWA and Original Applicant = DEPUY ORTHOPAEDICS, INC.
-
-